Grizzi, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 161
EU - Europa 134
AS - Asia 76
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 375
Nazione #
US - Stati Uniti d'America 161
CN - Cina 65
GB - Regno Unito 38
RU - Federazione Russa 21
IE - Irlanda 18
SE - Svezia 18
IT - Italia 17
FR - Francia 11
SG - Singapore 6
DE - Germania 4
UA - Ucraina 3
AU - Australia 2
CH - Svizzera 2
KR - Corea 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
FI - Finlandia 1
IR - Iran 1
TG - Togo 1
UZ - Uzbekistan 1
Totale 375
Città #
Chandler 50
Southend 37
Dublin 18
Woodbridge 12
Beijing 11
Jacksonville 11
Verona 9
Ashburn 8
Ann Arbor 7
Guangzhou 7
Wilmington 7
Jinan 6
Lawrence 5
Princeton 5
Shenyang 5
Tianjin 5
Hebei 4
Nanjing 4
New York 4
Detroit 3
Ningbo 3
Singapore 3
Zhengzhou 3
Augusta 2
Nanchang 2
Seoul 2
Sossano 2
Adliswil 1
Baku 1
Cattolica 1
Changsha 1
Fremont 1
Hangzhou 1
Houston 1
Kashan 1
Kent 1
Lomé 1
London 1
Melbourne 1
Negrar 1
Newark 1
Redwood City 1
Riva 1
Santiago Metropolitan 1
Seattle 1
Sindelfingen 1
Sofia 1
Sydney 1
Tashkent 1
Zurich 1
Totale 258
Nome #
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 95
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 86
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 71
Do immune checkpoint inhibitors need new studies methodology? 64
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies 60
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 8
Totale 384
Categoria #
all - tutte 1.387
article - articoli 1.083
book - libri 0
conference - conferenze 304
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 5 6 4 4 1 9 5 0 9
2020/202147 6 5 6 10 7 3 1 2 0 1 5 1
2021/202252 3 24 0 1 5 0 0 1 2 1 1 14
2022/2023115 5 21 5 21 11 22 1 10 16 0 0 3
2023/202446 3 5 4 2 6 8 1 3 2 6 6 0
2024/202529 6 7 5 11 0 0 0 0 0 0 0 0
Totale 384